Back to speakers

Lawrence SERFATY

MD, Professor of Hepatology and Chief of the Liver Diseases Department

France

City: Strasbourg

Institution: Hautepierre Hospital, Strasbourg University

Contact: lawrence.serfaty@sat.aphp.fr


Biography of Lawrence SERFATY

Lawrence Serfaty, MD, is Professor of Hepatology and Chief of the Liver Diseases Department, Hautepierre Hospital, University of Strasbourg, France. Dr Serfaty received his Medical degree from University of Paris-Sud and completed his Medical training at Saint-Antoine Hospital, Paris. Before moving to Strasbourg University in 2017, he was the Viral and Metabolic Liver Unit Head and Associate Professor of Medicine in the Department of Hepatology at Saint-Antoine Hospital. He is also Associate Researcher in the INSERM UMR_S938, University Pierre&Marie Curie, Paris 6, France.

Dr Serfaty began his research career studying viral HCV in the early 1990s and then focused on potential mechanisms of steatosis and its role in fibrogenesis in chronic HCV. He then extended his field of research to non-alcoholic fatty liver disease (NAFLD), by investigating mechanisms of liver injury associated with insulin resistance in obese patients as well as those with HIV-associated lipodystrophy. He is now focusing his research on global epidemiology of NAFLD and mechanisms of fibrogenesis in NASH.

Dr Serfaty has been involved in a number of trials evaluating new anti-HCV direct-acting antivirals or new targeting molecules in NASH. He has published more than 160 indexed papers. He is a member of the French Association for the Study of the Liver (AFEF) and the European Association for the Study of the Liver (EASL).

PHC's participations

10th PHC – 2017

Monday, January 30th 2017

NASH SESSION (chairman)

Tuesday, January 31st 2017

LUNCH WORKSHOPS - 13-How to manage patients with NASH? (chairman)

9th PHC – 2016

Monday, January 11th 2016

Follow-up of patients with SVR -

Tuesday, January 12th 2016

Lunch Workshops - Room 251 (chairman)

8th PHC – 2015

Monday, January 12th 2015

Predictors of response to IFN-based therapy -

7th PHC – 2014

Monday, January 13th 2014

Is there still a role for PEG IFN+RBV therapy? -

6th PHC – 2013

Monday, January 14th 2013

Interactive luncheons - Room 4

5th PHC – 2012

Tuesday, January 31st 2012

Lead in or no lead in ? (chairman) -

Interactive Luncheons - Room 5 -

4th PHC – 2011

Tuesday, January 18th 2011

Interactive luncheons: regional management issues - Room 3 -

2nd PHC – 2007

Monday, January 22nd 2007

4th session (chairman)

DAY 1 – Friday, August 28

Friday, August 28th 2015

Workshop 2: Management of acute alcoholic hepatitis (chairman)

Saturday, August 29th 2015

Patients monitoring after SVR -

Awards and Conclusion (chairman) -

10th PHC – 2017

Monday, January 30th 2017

NASH SESSION (chairman)

Tuesday, January 31st 2017

LUNCH WORKSHOPS - 13-How to manage patients with NASH? (chairman)

Jeunes Hépatologues Conférence

Friday, June 30th 2017

Conférence (chairman)

Saturday, July 01st 2017

RESTITUTION DES ATELIERS (chairman)

HÉPATITES VIRALES (chairman)

11th PHC – 2018

Monday, January 15th 2018

NASH SESSION (chairman)

Management of a patient with NASH in real life

CONTROVERSY: diagnosis of NASH (chairman)